Business · 21/05/2018Updated: 10/17/2026 · 1 min read
FDA Renews Anesthetic and Analgesic Drug Products Advisory Committee for 2 Years
Summary
The Food and Drug Administration (FDA) has renewed the Anesthetic and Analgesic Drug Products Advisory Committee for an additional 2 years, with the new charter set to expire on May 1, 2020
Original source language: Federal Register — Food and Drug AdministrationOpen original release →